Comparison of dexamethasone and Anti-D Immune globulin for immune thrombocytopenia purpura in children
Reviews in Clinical Medicine [RCM]. 2014; 1 (2): 61-65
en Inglés
| IMEMR
| ID: emr-175874
ABSTRACT
Different therapeutic options in children with immune thrombocytopenic purpura include observation alone, periodic treatment with corticosteroids, intravenous immunoglobulin [IVIG] or anti-D, chronic administration of immunosuppressive agents, and splenectomy. Preference of the type of therapy depends on the degree of thrombocytopenia and clinical bleeding manifestations. Dexamethasone is safe but its side effects are the main disadvantages for its usage. Anti-D is more expensive than dexamethason but the side effect is rare and not dangerous and response to treatment is assessed in approximately 3 days after infusion
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Inmunoglobulinas
/
Dexametasona
/
Niño
/
Corticoesteroides
/
Globulina Inmune rho(D)
/
Inmunosupresores
Límite:
Niño
/
Humanos
Idioma:
Inglés
Revista:
Rev. Clin. Med.
Año:
2014
Similares
MEDLINE
...
LILACS
LIS